<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34919494</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>10</EndPage>
          <MedlinePgn>1-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2021.2007708</ELocationID>
        <Abstract>
          <AbstractText>The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants' responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values &gt; .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kotta</LastName>
            <ForeName>Ibolya</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0002-5336-0152</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Psychology and Educational Sciences, Department of Applied Psychology, Babes-Bolyai University, Cluj-Napoca, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kalcza-Janosi</LastName>
            <ForeName>Kinga</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Psychology and Educational Sciences, Department of Applied Psychology, Babes-Bolyai University, Cluj-Napoca, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Szabo</LastName>
            <ForeName>Kinga</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Psychology and Educational Sciences, Department of Applied Psychology, Babes-Bolyai University, Cluj-Napoca, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marschalko</LastName>
            <ForeName>Eszter Eniko</ForeName>
            <Initials>EE</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Psychology and Educational Sciences, Department of Applied Psychology, Babes-Bolyai University, Cluj-Napoca, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>figshare</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>10.6084/m9.figshare.15090891</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000088823" MajorTopicYN="N">Vaccination Hesitancy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Covid-19</Keyword>
        <Keyword MajorTopicYN="Y">fear of Covid-19 vaccine</Keyword>
        <Keyword MajorTopicYN="Y">lack of confidence</Keyword>
        <Keyword MajorTopicYN="Y">risk perception</Keyword>
        <Keyword MajorTopicYN="Y">scale development</Keyword>
        <Keyword MajorTopicYN="Y">skepticism</Keyword>
        <Keyword MajorTopicYN="Y">vaccine hesitancy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
          <Hour>17</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34919494</ArticleId>
        <ArticleId IdType="pmc">PMC8928857</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2021.2007708</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Haleem A, Javaid M, Vaishya R.. 
Effects of COVID 19 pandemic in daily life. Curr Med Res Pract. 2020;10(2):78. doi:10.1016/j.cmrp.2020.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmrp.2020.03.011</ArticleId>
            <ArticleId IdType="pmc">PMC7147210</ArticleId>
            <ArticleId IdType="pubmed">32292804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alola AA, Olowu FB. The health scare of COVID-19 amidst pandemics and the immune-related pharmaceutical products spillovers in the USA. Environ Sci Pollut Res. 2020;27(36):45949–56. doi:10.1007/s11356-020-11195-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11356-020-11195-z</ArticleId>
            <ArticleId IdType="pmc">PMC7561703</ArticleId>
            <ArticleId IdType="pubmed">33064278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alola AA, Alola UV, and Sarkodie SA. The nCOVID-19 and financial stress in the USA: health is wealth. Environ Dev Sustainability. 2020;23:9367–78. doi: 10.1007/s10668-020-01029-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10668-020-01029-w</ArticleId>
            <ArticleId IdType="pmc">PMC7543967</ArticleId>
            <ArticleId IdType="pubmed">33052193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhopal S, Nielsen M. Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response. Arch Dis Child. 2020;106(2):113–14. doi:10.1136/archdischild-2020-318988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2020-318988</ArticleId>
            <ArticleId IdType="pubmed">32912868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;16:1–10. doi:10.1038/s41591-021-01454-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41591-021-01454-y</ArticleId>
            <ArticleId IdType="pmc">PMC8363502</ArticleId>
            <ArticleId IdType="pubmed">34272499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truong J, Bakshi S, Wasim A, Ahmad M, and Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health Promot Int. 2021;105:1–13. doi:10.1093/heapro/daab105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/heapro/daab105</ArticleId>
            <ArticleId IdType="pubmed">34244738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy. Hum Vaccines Immunother. 2013;9(8):1763–73. doi:10.4161/hv.24657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/hv.24657</ArticleId>
            <ArticleId IdType="pmc">PMC3906279</ArticleId>
            <ArticleId IdType="pubmed">23584253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId>
            <ArticleId IdType="pubmed">25896383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165–75. doi:10.1016/j.vaccine.2015.04.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2015.04.037</ArticleId>
            <ArticleId IdType="pubmed">25896384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford Coronavirus explanations, attitudes, and narratives survey (OCEANS) II. Psychol Med. 2020;11:1–34. doi:10.1017/S0033291720005188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0033291720005188</ArticleId>
            <ArticleId IdType="pmc">PMC7804077</ArticleId>
            <ArticleId IdType="pubmed">33305716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Determann D, de Bekker-grob EW, French J, Voeten HA, Richardus JH, Das E, Korfage IJ. Future pandemics and vaccination: public opinion and attitudes across three European countries. Vaccine. 2016;34(6):803–08. doi:10.1016/j.vaccine.2015.12.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2015.12.035</ArticleId>
            <ArticleId IdType="pubmed">26740251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myers LB, Goodwin R. Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health. 2011;11(1). doi:10.1186/1471-2458-11-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2458-11-15</ArticleId>
            <ArticleId IdType="pmc">PMC3024930</ArticleId>
            <ArticleId IdType="pubmed">21211000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robertson E, Reeve KS, Niedzwiedz CL, Moore J, Blake M, Green M, Katikireddi SV, Benzeval MJ. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain. 2021;94:41. doi:10.1101/2020.12.27.20248899.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2020.12.27.20248899</ArticleId>
            <ArticleId IdType="pmc">PMC7946541</ArticleId>
            <ArticleId IdType="pubmed">33713824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: what have we learned so far and what remains to be done?
Health Policy (New York). 2021;125(5):553–67. doi:10.1016/j.healthpol.2021.03.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.healthpol.2021.03.013</ArticleId>
            <ArticleId IdType="pmc">PMC7997052</ArticleId>
            <ArticleId IdType="pubmed">33820678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freeman D, Lambe S, Yu L-M, Freeman J, Chadwick A, Vaccari C, Waite F, Rosebrock L, Petit A, Vanderslott S, et al. Injection fears and COVID-19 vaccine hesitancy. Psychol Med. 2021;1–11. doi:10.1017/S0033291721002609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0033291721002609</ArticleId>
            <ArticleId IdType="pmc">PMC8220023</ArticleId>
            <ArticleId IdType="pubmed">34112276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rief W. Fear of adverse effects and COVID-19 vaccine hesitancy: recommendations of the treatment expectation expert group. JAMA Health Forum. 2021;2(4):e210804. doi:10.1001/jamahealthforum.2021.0804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamahealthforum.2021.0804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, Karukivi M, Lindfelt M, Antfolk J. Fearing the disease or the vaccine: the case of COVID-19. Pers Individ Dif. 2021;172(1):110590. doi:10.1016/j.paid.2020.110590.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.paid.2020.110590</ArticleId>
            <ArticleId IdType="pmc">PMC7832025</ArticleId>
            <ArticleId IdType="pubmed">33518869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccines Immunother. 2019;15(7–8):1615–27. doi:10.1080/21645515.2018.1564436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2018.1564436</ArticleId>
            <ArticleId IdType="pmc">PMC6783136</ArticleId>
            <ArticleId IdType="pubmed">30633623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36(5):660–67. doi:10.1016/j.vaccine.2017.12.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.12.043</ArticleId>
            <ArticleId IdType="pubmed">29289384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez VJ, Alcaide ML, Salazar AS, Montgomerie EK, Maddalon MJ, and Jones DL. Psychometric properties of a vaccine hesitancy scale adapted for COVID-19 vaccination among people with HIV. AIDS Behav. 2021;1–6. doi: 10.1007/s10461-021-03350-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10461-021-03350-5</ArticleId>
            <ArticleId IdType="pmc">PMC8210509</ArticleId>
            <ArticleId IdType="pubmed">34138378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennings W, Stoker G, Bunting H, Valgarðsson VO, Gaskell J, Devine D, McKay L, Mills MC. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines. 2021;9(6):593. doi:10.3390/vaccines9060593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines9060593</ArticleId>
            <ArticleId IdType="pmc">PMC8226842</ArticleId>
            <ArticleId IdType="pubmed">34204971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chadwick A, Kaiser J, Vaccari C, Freeman D, Lambe S, Loe BS, Vanderslott S, Lewandowsky S, Conroy M, Ross ARN, et al. Online social endorsement and Covid-19 vaccine hesitancy in the United Kingdom. Social Media. 2021;7(2):205630512110088. doi:10.1177/20563051211008817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/20563051211008817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumeister RF, Bratslavsky E, Finkenauer C, Vohs KD. Bad is stronger than good. Rev Gen Psychol. 2001;5(4):323–70. doi:10.1037/1089-2680.5.4.323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/1089-2680.5.4.323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marschalko EE, Kotta I, Kalcza-Janosi K, Szabo K, Psychological J-FS. Predictors of COVID-19 prevention behavior in Hungarian women across different generations. Front Psychol. 2021;12:10. doi:10.3389/fpsyg.2021.596543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyg.2021.596543</ArticleId>
            <ArticleId IdType="pmc">PMC7870484</ArticleId>
            <ArticleId IdType="pubmed">33574787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaCour M, Davis T. Vaccine skepticism reflects basic cognitive differences in mortality-related event frequency estimation. Vaccine. 2020;38(21):3790–99. doi:10.1016/j.vaccine.2020.02.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2020.02.052</ArticleId>
            <ArticleId IdType="pubmed">32169393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021;97:107724. doi:10.1016/j.intimp.2021.107724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2021.107724</ArticleId>
            <ArticleId IdType="pmc">PMC8078903</ArticleId>
            <ArticleId IdType="pubmed">33951558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo F, Ghanei Gheshlagh R, Dalvand S, Saedmoucheshi S, Li Q. Systematic review and meta-analysis of fear of COVID-19. Front Psychol. 2021:12:1311. doi:10.3389/fpsyg.2021.661078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyg.2021.661078</ArticleId>
            <ArticleId IdType="pmc">PMC8231929</ArticleId>
            <ArticleId IdType="pubmed">34177712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathews A, Mackintosh B, Fulcher EP. Cognitive biases in anxiety and attention to threat. Trends Cogn Sci. 1997;1(9):340–45. doi:10.1016/s1364-6613(97)01092-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1364-6613(97)01092-9</ArticleId>
            <ArticleId IdType="pubmed">21223944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Europe: COVID-19 vaccination rate by country 2021. Statista. [accessed 2021 Nov
20]https://www.statista.com/statistics/1196071/covid-19-vaccination-rate-in-europe-by-country/</Citation>
        </Reference>
        <Reference>
          <Citation>Williams B, Onsman A, and Brown T. Exploratory factor analysis: a five-step guide for novices. Australasian J Paramed. 2010;8(3):1–13. doi:10.33151/ajp.8.3.93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.33151/ajp.8.3.93</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahorsu DK, Lin C-Y, Imani V, Saffari M, Griffiths MD, and Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2020; 1–9. doi: 10.1007/s11469-020-00270-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11469-020-00270-8</ArticleId>
            <ArticleId IdType="pmc">PMC7100496</ArticleId>
            <ArticleId IdType="pubmed">32226353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jankovic S, Antonijevic G, Mirkovic S, Raspopovic K, Radoicic L, Putnik S, Zivkovic-Radojevic M, Vasic I, Nikolic B, Stanojevic D, et al. Surgical Fear Questionnaire (SFQ) - Serbian cultural adaptation. Vojnosanitetski Pregled. 2020;77(12):1266–70. doi:10.2298/vsp180410002j.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2298/vsp180410002j</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maridor M, Ruch S, Bangerter A, Emery V. Skepticism toward emerging infectious diseases and influenza vaccination intentions in nurses. J Health Commun. 2017;22(5):386–94. doi:10.1080/10810730.2017.1296509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10810730.2017.1296509</ArticleId>
            <ArticleId IdType="pubmed">28375808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Field A. Discovering statistics using SPSS: (and sex and drugs and rock “n” roll). London: Sage, Cop; 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980;88(3):588–606. doi:10.1037/0033-2909.88.3.588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/0033-2909.88.3.588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vandenberg RJ. Introduction: statistical and methodological myths and urban legends. Org Res Methods. 2006;9(2):194–201. doi:10.1177/1094428105285506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1094428105285506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tabachnick BG, and Fidell LS. Using multivariate statistics. 5th ed. Boston: Cop.: Pearson Education/Allyn &amp; Bacon; 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>Hooper D, Coughlan J, Mullen M. Structural equation modelling: guidelines for determining model fit. Electronic J Bus Res Methods. 2008;6:53–60.</Citation>
        </Reference>
        <Reference>
          <Citation>Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model. 1999;6(1):1–55. doi:10.1080/10705519909540118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10705519909540118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Browne M, Cudeck R. Single sample cross-validation indices for Covariance structures. Multivariate Behav Res. 1989;24(4):445–55. doi:10.1207/s15327906mbr2404_4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1207/s15327906mbr2404_4</ArticleId>
            <ArticleId IdType="pubmed">26753509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marsh HW, and Grayson D. Latent variable models of multitrait-multimethod data. In: Structural equation modeling. Concepts, issues, and applications ed. Hoyle, RH. Thousand Oaks (CA): Sage; 1995. p. 177–98.</Citation>
        </Reference>
        <Reference>
          <Citation>Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res. 2003;8:23–74.</Citation>
        </Reference>
        <Reference>
          <Citation>Bollen KA, New Incremental A. Fit index for general structural equation models. Sociol Methods Res. 1989;17(3):303–16. doi:10.1177/0049124189017003004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0049124189017003004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mulaik SA, James LR, Van Alstine J, Bennett N, Lind S, Stilwell CD. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105(3):430–45. doi:10.1037/0033-2909.105.3.430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/0033-2909.105.3.430</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
